Berodual 0.25 mg/ml + 0.5 mg/ml

Indication

Bronchospasm associated with chronic obstructive pulmonary disease (COPD), bronchial asthma, and other conditions with reversible airway obstruction. For use with electric nebulisers and respirators.

Ingredients

• Ipratropium bromide anhydrous 250 micrograms/ml
• Fenoterol hydrobromide 500 micrograms/ml

Direction

For inhalation only. For use with electric nebulisers. Adults: 1–2 ml (20–40 drops) per dose, up to 4 times daily. Dilute with physiological saline to 3–4 ml before nebulisation. As directed by physician.

Side effects

• Consult a doctor or pharmacist if you experience any adverse effects. Common effects may include dry mouth
• headache
• tremor
• increased heart rate
• or paradoxical bronchospasm
• stop use and seek medical advice if these occur.

Precautions

• Use with caution in patients with narrow
• angle glaucoma
• prostatic hyperplasia
• or bladder
• neck obstruction. Consult a doctor or pharmacist before use
• stop if irritation or allergic reaction occurs.